Ignite Creation Date:
2025-12-25 @ 1:45 AM
Ignite Modification Date:
2025-12-31 @ 7:38 PM
Study NCT ID:
NCT03206294
Status:
COMPLETED
Last Update Posted:
2019-02-04
First Post:
2017-06-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Impact of Pharmacist in Cardiology Service
Sponsor:
Fondation Hôpital Saint-Joseph
Organization:
Study Overview
Official Title:
Presence of a Clinical Pharmacist in a Cardiology Department: What Impact on the Management of Diabetic Patients Within Care Pathways? Example of Inpatient Cardiac Patients at GHPSJ
Status:
COMPLETED
Status Verified Date:
2018-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The coverage of the diabetes is a multidisciplinary care, with practitioners' implication(hospital and liberal), and other medical and paramedical profession: doctor, pharmacist, male nurse, nutritionist, etc. In fact there is a real importance of link between hospital and general medecine outside. That's why the pharmacist's presence during the hospitalization seems to be a good alternative to make the link between hospital and the outside pharmacist where patient take his treatment.
Hospital pharmacis proceed to a treatment conciliation at the entrance and at discharge.
By this conciliation the aim of the study is to show and quantify the impact of pharmacist presence on therapeutic target .
Hospital pharmacis proceed to a treatment conciliation at the entrance and at discharge.
By this conciliation the aim of the study is to show and quantify the impact of pharmacist presence on therapeutic target .
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: